| Name | Title | Contact Details |
|---|
BioDelivery Sciences International (NASDAQ: BDSI) is a specialty pharmaceutical company that is leveraging its novel and proprietary patented drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties, new applications of proven therapeutics. BDSI is focusing on developing products to meet unmet patient needs in the areas of pain management and addiction. BDSI's pain franchise consists of three products, two of which utilize the patented BioErodible MucoAdhesive (BEMA) drug delivery technology. ONSOLIS (fentanyl buccal soluble film) is approved in the U.S., Canada, E.U. (where it is marketed as BREAKYL) and Taiwan (where it is marketed as PAINKYL), for the management of breakthrough pain in opioid tolerant, adult patients with cancer. The commercial rights are licensed to Meda for all territories worldwide except for Taiwan (licensed to TTY Biopharm) and South Korea (licensed to Kunwha Pharmaceutical Co.). BDSI's second pain product using the BEMA technology, BEMA Buprenorphine, is in Phase 3 clinical trials for the treatment of moderate to severe chronic pain and is licensed on a worldwide basis to Endo Health Solutions. BDSI's third pain product in development is Clonidine Topical Gel for the treatment of painful diabetic neuropathy and was recently licensed from Arcion Therapeutics. In August 2013, BDSI filed an NDA for BUNAVAIL, a high dose formulation of buprenorphine in combination with naloxone for the maintenance treatment of opioid dependence. Under the 505(b) (2) regulatory statute, the NDA for BUNAVAIL is subject to a ten month review. BDSI's headquarters is located in Raleigh, North Carolina. For more information visit www.bdsi.com.
Founded in 1950, Miami Children's Hospital is South Florida’s only licensed specialty hospital exclusively for children. The 289-bed hospital is renowned for excellence in all aspects of pediatric medicine with several specialty programs ranked among the best in the nation in 2010 by U.S.News & World Report. The hospital has also been designated an American Nurses Credentialing Center (ANCC) Magnet facility, the nursing profession’s most prestigious institutional honor and is home to the largest pediatric teaching program in the southeastern United States. With a medical staff of more than 650 physicians and over 2,000 employees, the hospital is renowned for excellence in all aspects of pediatric medical care from birth through adolescence, offering more than 40 pediatric specialties and subspecialties, and is home to Florida’s only free-standing pediatric trauma center.
Cyntellect is dedicated to setting new standards in cell analysis, purification, and processing technology.
Med-Response Inc is a Bluefield, WV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The Health and Wellness Institute is a Providence, RI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.